Opinion

Video

Expert Insights on Biomarker Testing in Early-Stage Breast Cancer

Author(s):

Kelly E. McCann, MD, PhD,Sara A. Hurvitz, MD, FACP

Leading oncologists explore optimal biomarker testing strategies for early-stage breast cancer, examining the comparative advantages of tissue and liquid biopsies to guide personalized treatment decisions.

Video content above is prompted by the following:

  • What do you consider best practices for biomarker testing in early-stage breast cancer?
  • Identify key treatment approaches for patients with early-stage HR+ breast cancer.
Related Videos
Peter Schmid, MD, PhD, FRCP, discusses updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage TNBC.
1 expert in this video
1 expert in this video
David Rimm, MD, PhD
Vered Stearns, MD
1 expert in this video
1 expert in this video
Ruth M. O’Regan, MD
Related Content
November Recap
December 2nd 2024

Revisit Every OncLive On Air Episode From November 2024

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Breast Cancer
November 27th 2024

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC

MedNews Week
September 4th 2024

Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer

Jairam Krishnamurthy, MD, FACP
November 22nd 2024

Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer

Alberto Montero, MD, MBA, CPHQ, clinical director, Breast Cancer Medical Oncology Program, Diana Hyland Chair for Breast Cancer, University Hospitals Seidman Cancer Center
November 20th 2024

STK-478 May Be an Effective, Tolerable Treatment Alternative in PIK3CA-Mutant Breast and Gynecologic Cancers